Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions.

Nahmias Z, Nambudiri VE, Vleugels RA. Thalidomide and lenalidomide for the treatment of refractory dermatologic conditions. J Am Acad Dermatol. 2016 Jul; 75(1):210-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.